Rivaroxaban for thromboprophylaxis in acutely Ill medical patients [2]

New England Journal of Medicine

Volumn 368, Issue 20, 2013, Pages 1945-

  Vink, Roel ^a   Sohne, Maaike ^b  

^a TERGOOI HOSPITAL   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; RIVAROXABAN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

ACUTE DISEASE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; BRAIN HEMORRHAGE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DRUG EFFICACY; FOLLOW UP; HUMAN; LETTER; MALE; MENTAL DETERIORATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; TREATMENT OUTCOME; BLEEDING; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; FEMALE; NOTE; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ENOXAPARIN; FACTOR XA; FEMALE; HEMORRHAGE; HUMANS; MALE; MORPHOLINES; THIOPHENES; VENOUS THROMBOEMBOLISM;

EID: 84877788640     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1303641     Document Type: Letter

References (3)

1. Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med 2010;363:2487-98.
2. Bijsterveld NR, Moons AH, Meijers JC, et al. Rebound thrombin generation after heparin therapy in unstable angina: a randomized comparison between unfractionated and low-molecular-weight heparin. J Am Coll Cardiol 2002;39:811-7. (Pubitemid 34185328)
3. Palareti G, Legnani C, Guazzaloca G, et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants - a prospective study. Thromb Haemost 1994;72:222-6. (Pubitemid 24251284)